Opicapone: A third generation COMT inhibitor - Cure Parkinson's

Cure Parkinson's

27,098 members28,469 posts

Opicapone: A third generation COMT inhibitor

Farooqji profile image
1 Reply

Opicapone is used once daily as adjunctive to levodopa/carbidopa to reduce “off” periods in patients with Parkinson’s disease.

In clinical trials BIPARK I and II, 50 mg of opicapone once daily was shown to be noninferior to entacapone and reduced the mean off time by about 50 min when compared to placebo.

sciencedirect.com/science/a...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
1 Reply
tacato profile image
tacato

I started treatment with opicapone over a month ago. While it's early yet, I have seen no improvement.

Not what you're looking for?

You may also like...

Opicapone helps prolong plasma levodopa levels in patients with Parkinson’s

- Once-daily opicapone 50 mg with carbidopa/levodopa helped achieve and maintain plasma...
Farooqji profile image

Opicapone

Hello everyone, I was wondering if anyone has taken Opicapone 50 mg and if they have experienced...
Daisies22 profile image

Opicapone..feeling a bit woowooo...

Hi, I was prescribed Opicapone to extend my 'on' time after trying Entacapone which had made me...

opicapone

Hi everyone, my name is Axter and I live in Italy. These days my doctors have prescribed me...
Axter profile image

Enta- and opicapone experience

About a month ago I was prescribed Opicapone 50 mg which I took under medical supervision. Roughly...
Daisies22 profile image

Moderation team

See all
CPT_Aleksandra profile image
CPT_AleksandraAdministrator
CPT_Anaya profile image
CPT_AnayaAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.